Patient info Open main menu

Vardenafil Mylan 10 mg film-coated tablets – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg
Other strengths and forms:
Contains active substance:
ATC code:

Patient leaflet - Vardenafil Mylan 10 mg film-coated tablets

1. What Vardenafil is and what it is used for

Vardenafil contains the active substance vardenafil, a member of a class of medicines called phosphodiesterase type 5 inhibitors. They are used for the treatment of erectile dysfunction in adult men, a condition which implies difficulties in getting or keeping an erection.

At least one in ten men has trouble getting or keeping an erection at some time. There may be physical or psychological causes, or a mixture of both. Whatever the cause is, due to muscle and blood vessel changes not enough blood stays in the penis to make it hard or to keep it hard. Vardenafil will only work when you are sexually stimulated. It reduces the action of the natural chemical in your body which makes erections go away. Vardenafil allows an erection to last long enough for you to satisfactorily complete sexual activity.

2. What you need to know before you take Vardenafil

Do not take Vardenafil:

  • if you are allergic to vardenafil or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include a rash, itching, swollen face or lips and shortness of breath
  • If you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking Vardenafil Mylan.
  • if you are taking medicines containing nitrates, such as glycerol trinitrate for angina, or nitric oxide donors, such as amyl nitrite. Taking these medicines with vardenafil could seriously affect your blood pressure
  • if you are taking ritonavir or indinavir, medicines used to treat human immunodeficiency virus (HIV) infection
  • if you are over 75 years of age and are taking ketoconazole or itraconazole, anti‑fungal medicines
  • if you have a severe heart or liver problem
  • if you are having kidney dialysis
  • if you have recently had a stroke or heart attack
  • if you have or have had low blood pressure
  • if your family has a history of degenerative eye diseases (such as retinitis pigmentosa)
  • if you have ever had a condition involving loss of vision due to damage to the optic nerve from insufficient blood supply known as non‑arteritic ischemic optic neuropathy (NAION)
  • if you are taking riociguat. This drug is used to treat pulmonary arterial hypertension (i.e., high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (i.e., high blood pressure in the lungs secondary to blood clots). PDE5 inhibitors, such as vardenafil have been shown to increase the hypotensive effects of this medicine. If you are taking riociguat or are unsure tell your doctor. Warnings and precautions

Talk to your doctor or pharmacist before taking Vardenafil:

  • if you have heart trouble. It may be risky for you to have sex
  • if you suffer from irregular heart beat (cardiac arrhythmia) or inherited heart diseases affecting your electrocardiogram
  • if you have a physical condition affecting the shape of the penis. This includes conditions called angulation, Peyronie’s disease and cavernosal fibrosis
  • if you have an illness that can cause erections which won’t go away

    (priapism). These include sickle cell disease, multiple myeloma and leukaemia

  • if you are elderly
  • if you have low levels of potassium in your blood
  • if you have stomach ulcers (also called gastric or peptic ulcers)
  • if you have a bleeding disorder (such as haemophilia)
  • if you are using any other treatments for erection difficulties, see section

    ‘Other medicines and Vardenafil’).

Your doctor will check your medical history and give you a physical examination before you start taking Vardenafil to try and identify the cause of the erectile dysfunction.

During treatment

Serious skin reactions including Stevens‑Johnson syndrome, toxic epidermal necrolysis, have been reported in association with vardenafil treatment. Stop using Vardenafil Mylan and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.

If you experience sudden decrease or loss of vision or your vision is distorted or dimmed while you are taking Vardenafil Mylan, stop taking Vardenafil and contact your doctor immediately.

Children and adolescents

Vardenafil is not intended for use by children or adolescents under 18. Other medicines and Vardenafil

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Do not take Vardenafil with the following medicines:

  • nitrates, medicines for angina such as nicorandil or nitroglycerin, or nitric oxide donors, such as amyl nitrite. Taking these medicines with Vardenafil could seriously affect your blood pressure
  • riociguat
  • ritonavir or indinavir, medicines for HIV.

Some medicines may cause problems, especially these:

  • medicine for the treatment of arrhythmias, such as quinidine, procainamide, amiodarone or sotalol
  • ketoconazole or itraconazole, anti‑fungal medicines
  • erythromycin, or clarithromycin, macrolide antibiotics
  • alpha‑blockers, a type of medicine used to treat high blood pressure and enlargement of the prostate (as benign prostatic hyperplasia) such as tamsulosin, terazosin and alfuzosin
  • nifedipine, used to treat blood pressure and angina.

Do not use Vardenafil film‑coated tablets combined with any other treatment for erectile dysfunction.

Vardenafil with food, drink and alcohol:

  • You can take Vardenafil with or without food – but preferably not after a heavy or high‑fat meal as this may delay the effect.
  • Do not drink grapefruit juice when you use Vardenafil. It can interfere with the usual effect of the medicine.
  • Alcoholic drink can make erection difficulties worse.

Pregnancy and breast‑feeding

Vardenafil is not for use by women.

Driving and using machines

Vardenafil might make some people feel dizzy or affect their vision. If you feel dizzy, or if your vision is affected after taking Vardenafil do not drive or operate any tools or machines.

3. How to take Vardenafil

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is 10 mg.

Take a Vardenafil tablet about 25 to 60 minutes before sexual activity. With sexual stimulation, you may achieve an erection anywhere from 25 minutes up to four to five hours after taking Vardenafil:

  • Swallow one tablet with a glass of water.

Do not take Vardenafil more than once a day.

Tell your doctor if you think Vardenafil is too strong or too weak. He or she may suggest a switch to a different dose, depending on how well it works for you. If you have liver or severe kidney problems, you may start with a lower dose. If you take more Vardenafil than you should

Men who take too much Vardenafil may experience more side effects or may get severe back pain. If you take more Vardenafil than you should, tell your doctor.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

[ Page # 1 of 2 ]

Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks

Date / Remarks

Date / Remarks

Date / Remarks

15.09.2021 / KLD Shared

19.02.2025 / KLD Shared as per new task

Date / Remarks

dd / mm / yy dd / mm / yy 1 of 2

Die Line

NA

100%

25/02/25 14:00 ART-1335-02

ART-1335-02

2082824

NA

PL 04569/1697, PL 04569/1696,

PL 04569/1695

400538203, 400538204,

400538205

Mylan Laboratories Ltd, FDF 4

(Jedcherla, Hyderabad ), IN

N/A

NA

1

NA

NA

Myriad Pro

NA

9 pt

Safety updates

NA

NA

Adobe Indesign 2025

GB (UK)

LIT. (B/F) VARDENAFIL TABS (COMMON) GB V2

75082161

75070030

Printed Literature

1

Folded size - 110 x 40 mm

NA

NA

NA

40 gsm ITC Tribeni Paper

Supply Leaflet in Folded Form as Proposed Size

SOP-000464069_FORM-000647341_Version 3.0

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the effects are mild or moderate. Cases of sudden death, fast or altered heart beat, heart attack, chest pain, and trouble in cerebral circulation (including temporarily decreased blood flow to parts of the brain and bleeding in the brain) have been reported in men taking vardenafil. Most of the men who experienced these side effects had heart problems before taking this medicine. It is not possible to determine whether these events were directly related to vardenafil. Contact your doctor immediately and do not take Vardenafil if you notice the following:

Uncommon (may affect up to 1 in 100 people):

  • swelling of the face, mouth, lips, tongue, throat or neck causing difficulty breathing or swallowing.

Rare (may affect up to 1 in 1,000 people):

  • seizures
  • sudden chest pain which may spread to the neck or arm, with shortness of breath and a clammy feeling. These may be signs of a heart attack
  • abnormally fast heart beats
  • heavy or pressing sensation on your chest with chest pain and an increased shortness of breath on exercise (these may be signs of problems with your heart such as angina)
  • temporarily decreased blood flow to parts of the brain. Not known (cannot be estimated from the available data):
  • partial, sudden, temporary or permanent decrease or loss of vision, or distorted, dimmed, or blurred central vision in one or both eyes has been experienced by patients
  • sudden decrease or loss of hearing
  • sudden death
  • bleeding in the brain
  • bleeding from the penis.

Patients who have taken medicines similar to Vardenafil have also experienced the following:

  • numbness or weakness in the arms or legs, having one side of the face drop, headache, dizziness, confusion, sight or speech problems, one side of the face may be dropped. These are signs that the blood supply to the brain is cut off resulting in a stroke or if these signs are temporary, a transient ischaemic attack.

Other side effects include:

Very common (may affect more than 1 in 10 people):

  • headache.

Common (may affect up to 1 in 10 people):

  • dizziness
  • flushing
  • blocked or runny nose
  • indigestion.

Uncommon (may affect up to 1 in 100 people):

  • sleep problems
  • numbness, pain or the sensation of pins and needles in your arms, legs, hands or feet
  • sleepiness
  • problems with your sight, redness of the eye, effects on colour vision, eye pain and discomfort, light sensitivity
  • ringing in the ears (tinnitus); a spinning sensation when standing or sitting (vertigo)
  • fast heart beat or pounding heart
  • breathlessness
  • stuffy nose
  • acid reflux, inflamed stomach (gastritis). You may have pain, nausea, vomiting, vomiting blood or have blood in your stools
  • gut or stomach pain, diarrhoea, vomiting, feeling sick (nausea), dry mouth
  • raised levels of liver enzymes in your blood, which can be seen in a blood test
  • rash, reddened skin
  • back or muscle pain
  • increase in blood of a muscle enzyme (creatine phosphokinase), which can be seen in a blood test
  • muscle stiffness, cramping
  • prolonged erections
  • feeling unwell.

Rare (may affect up to 1 in 1,000 people):

  • inflammation of the eyes (conjunctivitis)
  • allergic reaction
  • anxiety
  • fainting
  • amnesia
  • increased pressure in the eye, watery eyes
  • high or low blood pressure
  • nose bleed
  • sensitivity of the skin to sun light
  • painful erections, which can last for a long time
  • chest pain.

Not known (frequency cannot be estimated from the available data):

  • blood in the urine (haematuria)
  • presence of blood in the semen (haematospermia).
  • Reddish non‑elevated, target‑like or circular patches on the trunk, often with central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin rashes can be preceded by fever and flu‑like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis)
  • Distorted, dimmed, or blurred central vision or sudden decrease of vision Reporting of side effects

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Vardenafil

This medicine does not require any special storage conditions. Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP:”. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Vardenafil contains

The active substance is vardenafil.

Each Vardenafil 5 mg film‑coated tablet contains 5 mg of vardenafil (as hydrochloride trihydrate).

Each Vardenafil 10 mg film‑coated tablet contains 10 mg of vardenafil (as hydrochloride trihydrate).

Each Vardenafil 20 mg film‑coated tablet contains 20 mg of vardenafil (as hydrochloride trihydrate).

The other ingredients of the tablets are:

Tablet‑core: microcrystalline cellulose, crospovidone, colloidal anhydrous silica, magnesium stearate.

Film‑coating: hypromellose, titanium dioxide (E171), macrogol, iron oxide yellow (E172), iron oxide red (E172).

What Vardenafil looks like and contents of the pack:

  • Vardenafil 5 mg: A brown film coated, round shaped, biconvex, bevelled edge tablet marked with ‘M5’ on one side of the tablet and ‘VL’ on the other side.
  • Vardenafil 10 mg: A brown film coated, round shaped, biconvex, bevelled edge tablet marked with ‘M’ over ‘10’ on one side of the tablet and ‘VL’ on the other side.
  • Vardenafil 20 mg: A brown film coated, round shaped, biconvex, bevelled edge tablet marked with ‘M’ over ‘20’ on one side of the tablet and ‘VL’ on the other side.

The tablets are provided in blister packs containing 2, 4, 8, 12 or 20 tablets and in perforated unit dose blister packs of 4 x 1 and 8 x 1 tablets. Vardenafil 20 mg tablets are also available in perforated unit dose blister packs of 12 x 1 and 20 x 1 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Mylan,

Potters Bar,

Hertfordshire,

EN6 1TL,

United Kingdom.

Manufacturers

McDermott Laboratories Limited T/A Gerard Laboratories, T/A Mylan Dublin, Unit 35/36 Baldoyle Industrial Estate,

Grange road,

Dublin 13,

Ireland.

Mylan Hungary Kft / Mylan Hungary Ltd,

Mylan utca 1,

Komarom,

H‑2900 Hungary.

Generics [UK] Limited,

Station Close,

Potters Bar,

EN6 1TL,

United Kingdom.

This leaflet was last revised in 03/2025. ART‑1335‑02

75082161

[ Page # 2 of 2 ]

Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks Date / Remarks 15.09.2021 / KLD Shared

19.02.2025 / KLD Shared as per new task

Date / Remarks

dd / mm / yy dd / mm / yy 2 of 2

Die Line

NA

100%

25/02/25 14:00 ART-1335-02

ART-1335-02

2082824

NA

PL 04569/1697, PL 04569/1696, PL 04569/1695

400538203, 400538204, 400538205

Mylan Laboratories Ltd, FDF 4 (Jedcherla, Hyderabad ), IN

N/A

NA

1

NA

NA

Myriad Pro

NA

9 pt

Safety updates

NA

NA

Adobe Indesign 2025

GB (UK)

LIT. (B/F) VARDENAFIL TABS (COMMON) GB V2

75082161

75070030

Printed Literature

1

Folded size - 110 x 40 mm

NA

NA

NA

40 gsm ITC Tribeni Paper

Supply Leaflet in Folded Form as Proposed Size

SOP-000464069_FORM-000647341_Version 3.0

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04569/1696

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Vardenafil Mylan 10 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Vardenafil
Strength 10 mg
Pharmaceutical form Oral tablet
10 mg: A brown film coated, round shaped, biconvex, bevelled edge tablet debossed with ‘M’ over ‘10’ on one side of the tablet and ‘VL’ on the other side, approximately 7 mm in diameter.
How is it taken Oral
Excipients Cellulose, microcrystalline, Crospovidone (Type A), Silica, colloidal anhydrous, Magnesium stearate, Hypromellose 2910, Titanium dioxide (E171), Macrogol 4000, Iron oxide yellow (E172), Iron oxide red (E172)
Pack sizes 4 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 30 months
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Urologicals, Drugs used in erectile dysfunction
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BE Drugs used in erectile dysfunction
          1. G04BE09 vardenafil
Marketing authorisation PL 04569/1696 (first authorised 3 October 2022)
Marketing authorisation holder Generics [UK] Limited t/a Mylan
Codes GTIN 5016695008400 · BNF 07040500

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.